ADARx Pharmaceuticals Raises $200M in Series C Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Page 12 - Commodore Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Commodore Capital Today - Breaking & Trending Today
$18M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying - Asana (NYSE:ASAN), CVB Financial (NASDAQ:CVBF)
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.
Source: benzinga.com
Raising a first-time fund? This is the worst time to do it in 10 years
Capital from LPs is drying up—especially for newbies.
Source: fortune.com
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 M
Proceeds to Further Advance Company’s Lead Clinical ProgramsSAN DIEGO--(BUSINESS WIRE)--ADARx Pharmaceuticals, Inc. (“ADARx” or “the Company”), a clinical stage biotechnology company developing next generation RNA therapeutics, today announced the successful close of an oversubscribed $200 million Series C financing...
Source: pharmiweb.com
Eva Renee Barnett Sells 2,725 Shares of Immunovant, Inc. (NASDAQ:IMVT) Stock
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) CFO Eva Renee Barnett sold 2,725 shares of Immunovant stock in a transaction on Wednesday, July 19th. The shares were sold at an average price of $24.94, for a total transaction of $67,961.50. Following the completion of the sale, the chief financial officer now directly owns 349,863 shares […]
Source: wkrb13.com